Neprilysin activity declines with age, contributing to amyloid-beta accumulation [52], and post-mortem brain samples from Alzheimer’s disease patients show reduced NEP expression and activity [53]. This evidence concerns the gene MME and early-onset autosomal dominant Alzheimer disease.